AKT1 and atopic eczema: The dysregulation of PI3K/AKT and MAPK signaling pathways have been implicated in various dermatological diseases, with focuses on hyperproliferative/hypoproliferative and inflammatory dermatoses, including wound, psoriasis, and atopic dermatitis (86, 87).